Combination of intravitreal bevacizumab and erythropoietin versus intravitreal bevacizumab alone for refractory diabetic macular edema: a randomized double-blind clinical trial

Morteza Entezari,Zahra Kiani Flavarjani,Alireza Ramezani,Humayon Nikkhah,Saeed Karimi,Hamid Fateh Moghadam,Narsis Daftarian,Mehdi Yaseri

Combination of intravitreal bevacizumab and erythropoietin versus intravitreal bevacizumab alone for refractory diabetic macular edema: a randomized double-blind clinical trial

2019

Morteza Entezari
Zahra Kiani Flavarjani
Alireza Ramezani
Humayon Nikkhah
Saeed Karimi
Hamid Fateh Moghadam
Narsis Daftarian
Mehdi Yaseri

Purpose To evaluate the effect of three intravitreal bevacizumab (IVB) injections alone or in combination with intravitreal erythropoietin (EPO) in the treatment of refractory diabetic macular edema (DME).

Keywords:

Erythropoietin
Clinical trial
Medicine
Macular edema
Anatomy
Bevacizumab
Ophthalmology
Diabetes mellitus
Refractory
diabetic macular edema
intravitreal bevacizumab
Visual acuity

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations